Literature DB >> 14572600

Hepatic mitochondrial beta-oxidation in patients with nonalcoholic steatohepatitis assessed by 13C-octanoate breath test.

Luca Miele, Antonio Grieco, Alessandro Armuzzi, Marcello Candelli, Alessandra Forgione, Antonio Gasbarrini, Giovanni Gasbarrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14572600     DOI： 10.1111/j.1572-0241.2003.07725.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  39 in total

1.  Pediatric nonalcoholic fatty liver disease: overview with emphasis on histology.

Authors:  Yoshihisa Takahashi; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Treatment options for nonalcoholic fatty liver disease.

Authors:  Brian Lam; Zobair M Younossi
Journal:  Therap Adv Gastroenterol       Date:  2010-03       Impact factor: 4.409

3.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

Review 4.  Mitochondrial fatty acid oxidation in obesity.

Authors:  Dolors Serra; Paula Mera; Maria Ida Malandrino; Joan Francesc Mir; Laura Herrero
Journal:  Antioxid Redox Signal       Date:  2012-10-05       Impact factor: 8.401

5.  Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Yu Yang; Arthur J McCullough; Susan Marczewski; Carole Bennett; Satish C Kalhan
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-05       Impact factor: 2.566

Review 6.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

7.  Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury.

Authors:  John P Thyfault; R Scott Rector; Grace M Uptergrove; Sarah J Borengasser; E Matthew Morris; Yongzhong Wei; Matt J Laye; Charles F Burant; Nathan R Qi; Suzanne E Ridenhour; Lauren G Koch; Steve L Britton; Jamal A Ibdah
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

Review 8.  Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Authors:  Megan J Reiniers; Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

9.  Exploring Liver Mitochondrial Function by 13C-Stable Isotope Breath Tests: Implications in Clinical Biochemistry.

Authors:  Emilio Molina-Molina; Harshitha Shanmugam; Domenica Di Palo; Ignazio Grattagliano; Piero Portincasa
Journal:  Methods Mol Biol       Date:  2021

10.  Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.

Authors:  Srinivasan Dasarathy; Takhar Kasumov; John M Edmison; Lourdes L Gruca; Carole Bennett; Clarita Duenas; Susan Marczewski; Arthur J McCullough; Richard W Hanson; Satish C Kalhan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-07-01       Impact factor: 4.052
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.